The combination product is indicated to treat either complicated intra-abdominal infections, where it is used in combination with metronidazole, or complicated urinary tract infections in patients with few or no other treatment options.
Jay M. Patel, PharmD
Advertisement
Jay Patel is a PGY-1 pharmacy resident at John Dempsey Hospital/UConn Health, University of Connecticut School of Pharmacy, Storrs, Conn.
Articles by Jay M. Patel, PharmD
Advertisement
Latest Updated Articles
- FDA approves ceftazidime-avibactam to treat two complicated infections
Published: July 10th 2015 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
Lower Baseline BMI Predicts Weight Loss At 6 Months With Liraglutide
2
Providers, Patients Show Favorable Perception of Remdesivir During COVID-19 Pandemic
3
PCV21 Shows Cost Effectiveness Compared With PCV15, PCV13, and PPSV23
4
Pharmacies Should Be Proactive in Expanding Clinical Services, Reimbursement Pathways | NCPA 2025
5
